Pulmonx (LUNG) EBT Margin Growth (1y) (2020 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -419.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 110.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -300.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 507.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -287.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 233.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 772.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -464.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 584.00 |
| 10 | Pulmonx | 67.30 Mn | -2.45 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 412.00 |
| Jun 30, 2025 | 1,049.00 |
| Mar 31, 2025 | 843.00 |
| Dec 31, 2024 | 1,548.00 |
| Sep 30, 2024 | 1,556.00 |
| Jun 30, 2024 | 2,004.00 |
| Mar 31, 2024 | 3,633.00 |
| Dec 31, 2023 | 2,025.00 |
| Sep 30, 2023 | 2,096.00 |
| Jun 30, 2023 | 1,128.00 |
| Mar 31, 2023 | 3,788.00 |
| Dec 31, 2022 | 277.00 |
| Sep 30, 2022 | -2,852.00 |
| Jun 30, 2022 | 90.00 |
| Mar 31, 2022 | -1,151.00 |
| Dec 31, 2021 | 59.00 |
| Sep 30, 2021 | -4,053.00 |
| Jun 30, 2021 | 21,720.00 |
| Mar 31, 2021 | -5,252.00 |
| Dec 31, 2020 | -5,066.00 |
| Sep 30, 2020 | 1,073.00 |